Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-349.78%
operating margin TTM
-324.38%
revenue TTM
21.76 Million
revenue per share TTM
0.96$
valuation ratios | |
|---|---|
| pe ratio | -8.01 |
| peg ratio | -0.18 |
| price to book ratio | 4.75 |
| price to sales ratio | 27.92 |
| enterprise value multiple | -8.65 |
| price fair value | 4.75 |
profitability ratios | |
|---|---|
| gross profit margin | 71.11% |
| operating profit margin | -324.38% |
| pretax profit margin | -342.43% |
| net profit margin | -349.78% |
| return on assets | -23.55% |
| return on equity | -50.32% |
| return on capital employed | -28.89% |
liquidity ratio | |
|---|---|
| current ratio | 3.12 |
| quick ratio | 2.98 |
| cash ratio | 0.48 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 615.88 |
| operating cycle | 1,002.46 |
| days of payables outstanding | 339.67 |
| cash conversion cycle | 662.79 |
| receivables turnover | 0.94 |
| payables turnover | 1.07 |
| inventory turnover | 0.59 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.24 |
| debt equity ratio | 0.60 |
| long term debt to capitalization | 0.29 |
| total debt to capitalization | 0.37 |
| interest coverage | -1,027.14 |
| cash flow to debt ratio | -1.08 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.27 |
| cash per share | 5.49 |
| operating cash flow per share | -2.26 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.08 |
| short term coverage ratios | -3.45 |
| capital expenditure coverage ratio | -544.47 |
Frequently Asked Questions
When was the last time Orchard Therapeutics plc (NASDAQ:ORTX) reported earnings?
Orchard Therapeutics plc (ORTX) published its most recent earnings results on 13-11-2023.
What is Orchard Therapeutics plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Orchard Therapeutics plc (NASDAQ:ORTX)'s trailing twelve months ROE is -50.32%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Orchard Therapeutics plc (ORTX) currently has a ROA of -23.55%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ORTX's net profit margin stand at?
ORTX reported a profit margin of -349.78% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ORTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.12 in the most recent quarter. The quick ratio stood at 2.98, with a Debt/Eq ratio of 0.60.